ECOG-ACRIN EA2165 Primary Category: Radiation Oncology, Treatment Protocols Disease Category: Anal, Gastrointestinal Status: Open A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer NCT#03233711 (Click for More Info)